Cargando…
Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883534/ https://www.ncbi.nlm.nih.gov/pubmed/34854280 http://dx.doi.org/10.3324/haematol.2021.280139 |
| _version_ | 1784659950448934912 |
|---|---|
| author | Candon, Sophie Lémée, Véronique Lévêque, Emilie Etancelin, Pascaline Paquin, Cédric Carette, Marion Contentin, Nathalie Bobée, Victor Alani, Mustafa Cardinaël, Nathalie Leprêtre, Stéphane Camus, Vincent Bouclet, Florian Boulet, Edwige Ménard, Anne-Lise Lanic, Hélène Stamatoullas, Aspasia Lemasle, Emilie Pépin, Louis-Ferdinand Richard, Doriane Dubois, Sydney Tilly, Hervé Dalleac, Alain Plantier, Jean-Christophe Etienne, Manuel Jardin., Fabrice |
| author_facet | Candon, Sophie Lémée, Véronique Lévêque, Emilie Etancelin, Pascaline Paquin, Cédric Carette, Marion Contentin, Nathalie Bobée, Victor Alani, Mustafa Cardinaël, Nathalie Leprêtre, Stéphane Camus, Vincent Bouclet, Florian Boulet, Edwige Ménard, Anne-Lise Lanic, Hélène Stamatoullas, Aspasia Lemasle, Emilie Pépin, Louis-Ferdinand Richard, Doriane Dubois, Sydney Tilly, Hervé Dalleac, Alain Plantier, Jean-Christophe Etienne, Manuel Jardin., Fabrice |
| author_sort | Candon, Sophie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8883534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88835342022-03-18 Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas Candon, Sophie Lémée, Véronique Lévêque, Emilie Etancelin, Pascaline Paquin, Cédric Carette, Marion Contentin, Nathalie Bobée, Victor Alani, Mustafa Cardinaël, Nathalie Leprêtre, Stéphane Camus, Vincent Bouclet, Florian Boulet, Edwige Ménard, Anne-Lise Lanic, Hélène Stamatoullas, Aspasia Lemasle, Emilie Pépin, Louis-Ferdinand Richard, Doriane Dubois, Sydney Tilly, Hervé Dalleac, Alain Plantier, Jean-Christophe Etienne, Manuel Jardin., Fabrice Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-12-02 /pmc/articles/PMC8883534/ /pubmed/34854280 http://dx.doi.org/10.3324/haematol.2021.280139 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Candon, Sophie Lémée, Véronique Lévêque, Emilie Etancelin, Pascaline Paquin, Cédric Carette, Marion Contentin, Nathalie Bobée, Victor Alani, Mustafa Cardinaël, Nathalie Leprêtre, Stéphane Camus, Vincent Bouclet, Florian Boulet, Edwige Ménard, Anne-Lise Lanic, Hélène Stamatoullas, Aspasia Lemasle, Emilie Pépin, Louis-Ferdinand Richard, Doriane Dubois, Sydney Tilly, Hervé Dalleac, Alain Plantier, Jean-Christophe Etienne, Manuel Jardin., Fabrice Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas |
| title | Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas |
| title_full | Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas |
| title_fullStr | Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas |
| title_full_unstemmed | Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas |
| title_short | Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas |
| title_sort | dissociated humoral and cellular immune responses after a three-dose schema of bnt162b2 vaccine in patients receiving anti-cd20 monoclonal antibody maintenance treatment for b-cell lymphomas |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883534/ https://www.ncbi.nlm.nih.gov/pubmed/34854280 http://dx.doi.org/10.3324/haematol.2021.280139 |
| work_keys_str_mv | AT candonsophie dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT lemeeveronique dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT levequeemilie dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT etancelinpascaline dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT paquincedric dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT carettemarion dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT contentinnathalie dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT bobeevictor dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT alanimustafa dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT cardinaelnathalie dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT lepretrestephane dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT camusvincent dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT boucletflorian dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT bouletedwige dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT menardannelise dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT lanichelene dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT stamatoullasaspasia dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT lemasleemilie dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT pepinlouisferdinand dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT richarddoriane dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT duboissydney dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT tillyherve dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT dalleacalain dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT plantierjeanchristophe dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT etiennemanuel dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas AT jardinfabrice dissociatedhumoralandcellularimmuneresponsesafterathreedoseschemaofbnt162b2vaccineinpatientsreceivinganticd20monoclonalantibodymaintenancetreatmentforbcelllymphomas |